首页 › 非小细胞肺癌 › 康涅狄格州 › Bridgeport
Bridgeport CT 非小细胞肺癌临床试验
14项针对 非小细胞肺癌的研究正在 Bridgeport及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
招募中3 期
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 距离 4 英里
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 距离 5 英里
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- Smilow Cancer Hospital - Trumbull, Trumbull · 距离 4 英里
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
招募中3 期
- University Hospital at Stony Brook ( Site 0054), Stony Brook · 距离 18 英里
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
招募中3 期
- Research Site, Stony Brook · 距离 18 英里
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
招募中2/3 期
- Suny-Stony Brook University Cancer Center, Stony Brook · 距离 18 英里
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
招募中1 期
- New york cancer and blood specialists - Oncology, Port Jefferson Station · 距离 19 英里
- New york cancer and blood specialists - Oncology, Port Jefferson Station · 距离 19 英里
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
招募中3 期
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Port Jefferson Station · 距离 19 英里
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
招募中1/2 期
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 距离 4 英里
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 距离 4 英里
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 距离 5 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 距离 4 英里
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 距离 5 英里
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 距离 4 英里
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 距离 5 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 距离 4 英里
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 距离 5 英里
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Bridgeport的其他研究
- 乳腺癌21 项研究
- 肺癌13 项研究
- 急性髓系白血病12 项研究
- 心血管疾病9 项研究
- 癌症（所有类型）8 项研究
- 头颈鳞状细胞癌8 项研究
- 转移性癌症7 项研究
- 心力衰竭7 项研究
- 脑动脉瘤6 项研究
- 多发性骨髓瘤6 项研究
- 前列腺癌6 项研究
- 卵巢癌5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。